Literature DB >> 7937555

Disposition of azole antifungal agents. III. Binding of fluconazole and other azoles in rat liver.

C M Ervine1, J B Houston.   

Abstract

It has been shown for the azole antifungal agents, ketoconazole and DTP, that hepatic binding, is a major determinant of their volume of distribution and this observation is of particular interest in view of the well-documented avid binding of azoles to cytochromes P450. Whilst the hepatic binding characteristics of these two compounds are similar, their hepatic clearance differs markedly in terms of the rate of metabolism and the number and nature of metabolites produced. Fluconazole is a bis-triazole drug similar in structure to DTP but not subject to metabolism in rat. We have demonstrated by means of steady-state infusion studies the clearance of this azole (1.85ml/min/kg) to be independent of blood concentration over a 0.01-50mg/L range. Also fluconazole plasma protein binding is minimal (9.5%) and its blood:plasma ratio unity over a similar concentration range. Liver:blood partition coefficients for fluconazole are concentration dependent ranging from 30 to 2. The volume of distribution term is also nonlinear with concentration and can be correlated with the liver:blood partition coefficient. These findings are discussed together with earlier documented data on ketoconazole and DTP in terms of a tissue binding role for hepatic cytochromes P450. The similarity in behaviour of the hepatic partitioning of the three azoles contrasts markedly with the nature of (or lack of) hepatic metabolism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7937555     DOI: 10.1023/a:1018918917046

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

Review 2.  Factors affecting drug metabolism.

Authors:  J R Gillette
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

3.  A rapid and simple procedure for chronic cannulation of the rat jugular vein.

Authors:  P G Harms; S R Ojeda
Journal:  J Appl Physiol       Date:  1974-03       Impact factor: 3.531

4.  Isolation of the gene for cytochrome P450L1A1 (lanosterol 14 alpha-demethylase) from Candida albicans.

Authors:  D R Kirsch; M H Lai; J O'Sullivan
Journal:  Gene       Date:  1988-09-07       Impact factor: 3.688

Review 5.  Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections.

Authors:  R C Heel; R N Brogden; A Carmine; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

6.  The interaction of representative members from two classes of antimycotics--the azoles and the allylamines--with cytochromes P-450 in steroidogenic tissues and liver.

Authors:  I Schuster
Journal:  Xenobiotica       Date:  1985-06       Impact factor: 1.908

7.  Inhibition of human hepatic and placental xenobiotic monooxygenases by imidazole antimycotics.

Authors:  M Pasanen; T Taskinen; M Iscan; E A Sotaniemi; M Kairaluoma; O Pelkonen
Journal:  Biochem Pharmacol       Date:  1988-10-15       Impact factor: 5.858

8.  Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver.

Authors:  J J Sheets; J I Mason
Journal:  Drug Metab Dispos       Date:  1984 Sep-Oct       Impact factor: 3.922

9.  Disposition of azole antifungal agents. II. Hepatic binding and clearance of dichlorophenyl-bis-triazolylpropanol (DTP) in the rat.

Authors:  H L Bomont; M H Tarbit; M J Humphrey; J B Houston
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

10.  A comparative study of 1-substituted imidazole and 1,2,4-triazole antifungal compounds as inhibitors of testosterone hydroxylations catalysed by mouse hepatic microsomal cytochromes P-450.

Authors:  S A Ballard; A Lodola; M H Tarbit
Journal:  Biochem Pharmacol       Date:  1988-12-15       Impact factor: 5.858

View more
  3 in total

Review 1.  Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Authors:  K Venkatakrishnan; L L von Moltke; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2000-02       Impact factor: 6.447

2.  Fluconazole distribution to the brain: a crossover study in freely-moving rats using in vivo microdialysis.

Authors:  H Yang; Q Wang; W F Elmquist
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

3.  The design and validation of a novel intravenous microdialysis probe: application to fluconazole pharmacokinetics in the freely-moving rat model.

Authors:  H Yang; Q Wang; W F Elmquist
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.